Brief report
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans
Siyu Fua, Dhamina Karimb, Jhon Prietoc, Domingo Balderramod, Javier Diaz Ferrere, Angelo Z. Mattosf, Marco Arreseg, Enrique Carrerah, Jeffrey Oliveiraa, Jose D. Debesa,b,i, Andre Boonstraa,
Corresponding author
a Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
b School of Public Health, University of Minnesota, Minneapolis, MN, USA
c Centro de Enfermedades Hepaticas y Digestivas, Bogota, Distrito Capital de Bogota, Colombia
d Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba, Cordoba, Argentina
e Facultad de Medicina, Universidad de San Martin de Porres, Lima, Perú
f Graduate Program in Medicine: Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil
g Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
h Hospital Especialidades Eugenio Espejo, Universidad San Francisco de Quito, Quito, Ecuador
i Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Ver másRead
1096
Timeswas read the article
244
Total PDF
852
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 4 | 22 |
| 2025 11 | 48 | 14 | 62 |
| 2025 10 | 42 | 7 | 49 |
| 2025 9 | 30 | 18 | 48 |
| 2025 8 | 45 | 20 | 65 |
| 2025 7 | 47 | 10 | 57 |
| 2025 6 | 33 | 11 | 44 |
| 2025 5 | 54 | 4 | 58 |
| 2025 4 | 30 | 0 | 30 |
| 2025 3 | 38 | 10 | 48 |
| 2025 2 | 37 | 8 | 45 |
| 2025 1 | 57 | 4 | 61 |
| 2024 12 | 21 | 2 | 23 |
| 2024 11 | 35 | 6 | 41 |
| 2024 10 | 26 | 2 | 28 |
| 2024 9 | 26 | 7 | 33 |
| 2024 8 | 30 | 6 | 36 |
| 2024 7 | 22 | 3 | 25 |
| 2024 6 | 34 | 8 | 42 |
| 2024 5 | 23 | 9 | 32 |
| 2024 4 | 35 | 25 | 60 |
| 2024 3 | 25 | 8 | 33 |
| 2024 2 | 12 | 9 | 21 |
| 2024 1 | 17 | 9 | 26 |
| 2023 12 | 44 | 16 | 60 |
| 2023 11 | 23 | 24 | 47 |
Show all
